NEWS
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
BioRestorative Therapies has received a Notice of Allowance from the Israel Patent Office for its ThermoStem® technology platform. This marks the 14th international patent outside the U.S. for this technology. The patent covers brown adipose derived stem cell (BADSC) aggregates, encapsulation systems, and treatment methods. The company believes ThermoStem®-based BADSCs could offer better efficacy and tolerability compared to GLP-1 drugs. In May 2024, BioRestorative announced development of an exosome-based biologic program targeting obesity and plans to file a Drug Master File with the FDA. The company is also in discussions with an undisclosed regenerative medicine company regarding potential licensing of ThermoStem® intellectual property.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2878Followers
108Following
30KVisitors
Follow